Dna Methyltransferase-3b (dnmt3b) in Oral Cancer (oc) Development.

P. Saintigny,J. Jelinek,C. R. Pickering,W. Lang,M. J. Frederick,L. Zhang,H. Ren,V. Papadimitrakopoulou,J. J. Lee,E. S. Kim,Y. H. Fan,A. K. El-Naggar,W. K. Hong,J. Myers,J. J. Issa,S. M. Lippman,L. Mao
DOI: https://doi.org/10.1200/jco.2011.29.15_suppl.1506
IF: 45.3
2011-01-01
Journal of Clinical Oncology
Abstract:1506 Background: We have reported that a gene expression signature including DNMT3B canpredict OC development (dvlpt) in patients (pts) with oral preneoplasia (OPL). This led us to study OPL DNA methylation profiles. Methods: Gene expression profiles of 86 prospectively collected OPL with a median follow-up (fu) of 6.1 years (yrs), including 35 who developed OC, were used to compute a univariate Cox model for DNMT1, 3A and 3B. Methylated CpG island amplification method was used to study 12 OPL who developed (group A), and 12 OPL who did not develop (group B) OC, with a median fu of 2.2 yrs and 7.6 yrs respectively. DNA was SmaI/XmaI digested, amplified, labeled (each OPL of group A being compared to one OPL of group B), and hybridized on a chip covering 6,647 autosomal genes. Genes differentially methylated were defined by an absolute log2 ratio > 1, at least 2 probes showing the same effect, and an absolute minimal distance to the transcription starting site < 1kb. Their pattern of expression was analyzed using independent publicly available gene expression profiles from 37 OC and 20 matched normal (NM) mucosa. Results: DNMT3B gene expression, but not DNMT1 and DNMT3A, was associated with OC dvlpt (hazard ratio=7.7, 95% confidence interval: 3.3-18.6, P <0.0001), and did not correlate with proliferation markers. Hypermethylated genes in pts who developed OC had a significant overlap across the 12 comparisons, whereas hypomethylated genes were random. Log2 ratios were averaged across the 12 comparisons, and 55 autosomal genes hypermethylated in pts who developed OC were identified, consistent with a CpG island methylation phenotype (CIMP) occurring early during OC dvlpt. These genes participate in signal transduction, morphogenesis and dvlpt, and some were previously reported to be upregulated by demethylating agents. Using gene expression profiles from an independent study, the vast majority of the 55 genes were downregulated in OC vs. NM mucosa. Unsupervised hierarchical clustering using the 55 genes, allowed to separate OC and NM mucosa almost perfectly in two distinct groups. Conclusions: DNMT3B gene expression is a strong predictor of OC dvlpt. CIMP may occur early in OC dvlpt, and may be amenable to new chemoprevention strategies.
What problem does this paper attempt to address?